These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 21325656)
21. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy]. Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951 [TBL] [Abstract][Full Text] [Related]
22. Apical hypertrophic cardiomyopathy associated with multiple coronary artery-left ventricular fistulae: a report of a case and review of the literature. Dresios C; Apostolakis S; Tzortzis S; Lazaridis K; Gardikiotis A Eur J Echocardiogr; 2010 May; 11(4):E9. PubMed ID: 19995797 [TBL] [Abstract][Full Text] [Related]
23. Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience. Silva C; Moon JC; Elkington AG; John AS; Mohiaddin RH; Pennell DJ J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1076-9. PubMed ID: 18163027 [TBL] [Abstract][Full Text] [Related]
24. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. Soriano CJ; Ridocci F; Estornell J; Jimenez J; Martinez V; De Velasco JA J Am Coll Cardiol; 2005 Mar; 45(5):743-8. PubMed ID: 15734620 [TBL] [Abstract][Full Text] [Related]
25. Images in cardiovascular medicine. Covered stent septal ablation for hypertrophic obstructive cardiomyopathy: initial success but ultimate failure resulting from collateral formation. Fifer MA; Yoerger DM; Picard MH; Vlahakes GJ; Palacios IF Circulation; 2003 Jul; 107(25):3248-9. PubMed ID: 12835408 [No Abstract] [Full Text] [Related]
26. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. Popović ZB; Kwon DH; Mishra M; Buakhamsri A; Greenberg NL; Thamilarasan M; Flamm SD; Thomas JD; Lever HM; Desai MY J Am Soc Echocardiogr; 2008 Dec; 21(12):1299-305. PubMed ID: 19041572 [TBL] [Abstract][Full Text] [Related]
27. Danon disease: characteristic late gadolinium enhancement pattern on cardiac magnetic resonance imaging. Dara BS; Rusconi PG; Fishman JE Cardiol Young; 2011 Dec; 21(6):707-9. PubMed ID: 21733342 [TBL] [Abstract][Full Text] [Related]
28. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging. Yan AT; Gibson CM; Larose E; Anavekar NS; Tsang S; Solomon SD; Reynolds G; Kwong RY J Cardiovasc Magn Reson; 2006; 8(6):831-7. PubMed ID: 17060106 [TBL] [Abstract][Full Text] [Related]
29. When two tests are better than one: adding late gadolinium enhancement to first-pass perfusion cardiovascular magnetic resonance. Kramer CM J Am Coll Cardiol; 2006 Apr; 47(8):1639-40. PubMed ID: 16631002 [No Abstract] [Full Text] [Related]
30. Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy. Melacini P; Corbetti F; Calore C; Pescatore V; Smaniotto G; Pavei A; Bobbo F; Cacciavillani L; Iliceto S Int J Cardiol; 2008 Aug; 128(3):364-73. PubMed ID: 17643520 [TBL] [Abstract][Full Text] [Related]
32. Contrast-enhanced magnetic resonance imaging as the newest tool to detect transplant coronary artery disease. Goldschmidt-Clermont PJ; Dong C J Am Coll Cardiol; 2008 Sep; 52(14):1168-9. PubMed ID: 18804745 [No Abstract] [Full Text] [Related]
33. Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy. Abdel-Aty H; Cocker M; Strohm O; Filipchuk N; Friedrich MG J Magn Reson Imaging; 2008 Jul; 28(1):242-5. PubMed ID: 18581348 [TBL] [Abstract][Full Text] [Related]
34. Myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by delayed-enhanced magnetic resonance imaging. Sato Y; Matsumoto N; Kunimasa T; Matsuo S; Yoda S; Tani S; Kunimoto S; Saito S; Hirayama A Int J Cardiol; 2008 Dec; 131(1):e41-3. PubMed ID: 17920709 [TBL] [Abstract][Full Text] [Related]
35. Incremental value of cardiovascular magnetic resonance imaging in the differential diagnosis of hypertrophic cardiomyopathy. Eitel I; Gutberlet M; Thiele H Eur Heart J; 2009 Aug; 30(16):1939. PubMed ID: 19457924 [No Abstract] [Full Text] [Related]
36. Vanishing asymmetric septal hypertrophy in a patient with hypertrophic obstructive cardiomyopathy. Shim CY; Yoon SB; Kim YJ; Ha JW; Chung N J Am Coll Cardiol; 2011 May; 57(19):e213. PubMed ID: 21545939 [No Abstract] [Full Text] [Related]
37. Visual estimation of the extent of myocardial hyperenhancement on late gadolinium-enhanced CMR in patients with hypertrophic cardiomyopathy. Doesch C; Huck S; Böhm CK; Michaely H; Fluechter S; Haghi D; Dinter D; Borggrefe M; Papavassiliu T Magn Reson Imaging; 2010 Jul; 28(6):812-9. PubMed ID: 20409668 [TBL] [Abstract][Full Text] [Related]
38. Regional abnormalities of myocardial deformation in patients with hypertrophic cardiomyopathy: correlations with delayed enhancement in cardiac magnetic resonance. Ghio S; Revera M; Mori F; Klersy C; Raisaro A; Raineri C; Serio A; Pasotti M; Visconti LO Eur J Heart Fail; 2009 Oct; 11(10):952-7. PubMed ID: 19789398 [TBL] [Abstract][Full Text] [Related]
39. Calcified constrictive pericarditis can hide other cardiac diseases! Bosser G; Maurier F; Juillière Y Arch Cardiovasc Dis; 2009 Apr; 102(4):337-9. PubMed ID: 19427612 [No Abstract] [Full Text] [Related]
40. Clinical applications of cardiac magnetic resonance imaging. Pilz G; Heer T; Harrer E; Ali E; Hoefling B Minerva Cardioangiol; 2009 Jun; 57(3):299-313. PubMed ID: 19513011 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]